article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Discover the leading patient adherence pharmaceutical companies.

Leads 52
article thumbnail

Leading API chemical companies in contract marketing

Pharmaceutical Technology

The growing demand from customers and pressures from global competitors have increased the significance of active pharmaceutical ingredients (API) chemical companies in the pharmaceutical industry supply chain. The post Leading API chemical companies in contract marketing appeared first on Pharmaceutical Technology.

Leads 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Leading commercial packaging companies in contract marketing

Pharmaceutical Technology

Pharmaceutical Technology has listed some of the leading contract commercial packaging companies, based on its intel, insights and decades-long experience in the sector. The post Leading commercial packaging companies in contract marketing appeared first on Pharmaceutical Technology.

Leads 52
article thumbnail

ISPOR 2023: A Focus on Quality

Prognos Health

Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth.

article thumbnail

ISPOR 2023: A Focus on Quality

Prognos Health

Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth.

article thumbnail

A Powerful Point-of-Sale Partnership that Delivers on the Promise of Affordable Insulin

PM360

In March of this year the three largest insulin manufacturers announced a dramatic reduction in the price of many commonly prescribed insulins and a monthly out-of-pocket (OOP) cap of $35 that went into effect in May. for only $35. “We References: 1.

Retail 52
article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

He leads the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital in Boston. Meanwhile, the top 25 pharmaceutical companies reported a “healthy average operating margin of 22 percent” at the end of 2017, according to an analysis by GlobalData. In my opinion, PhRMA has zero credibility.

Pharma 255